Schroder Investment Management Group Halozyme Therapeutics, Inc. Transaction History

Schroder Investment Management Group

$94.5 Billion
Q3 2024

A detailed history of Schroder Investment Management Group transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 146,339 shares of HALO stock, worth $7.73 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

146,339

Previous 14,580 903.7%

Holding current value

$7.73 Million

Previous $763,000 997.25%

% of portfolio

0.01%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$51.3 - $64.42 $6.76 Million - $8.49 Million	131,759 Added 903.7%	146,339 $8.37 Million
Q2 2024 Aug 12, 2024	SELL	$37.81 - $52.4 $5.71 Million - $7.91 Million	-150,999 Reduced 91.19%	14,580 $763,000
Q1 2024 May 14, 2024	BUY	$33.68 - $41.95 $3.48 Million - $4.34 Million	103,379 Added 166.2%	165,579 $6.74 Million
Q4 2023 Feb 13, 2024	BUY	$33.32 - $42.1 $2.07 Million - $2.62 Million	62,200 New	62,200 $2.3 Million
Q2 2023 Aug 11, 2023	SELL	$30.28 - $38.74 $15.7 Million - $20 Million	-516,908 Reduced 96.64%	17,952 $647,000
Q1 2023 May 11, 2023	BUY	$32.86 - $55.7 $14.2 Million - $24.1 Million	432,043 Added 420.21%	534,860 $20.4 Million
Q4 2022 Feb 10, 2023	BUY	$40.06 - $59.44 $2.47 Million - $3.66 Million	61,620 Added 149.57%	102,817 $5.85 Million
Q3 2022 Nov 10, 2022	BUY	$38.53 - $51.78 $1.59 Million - $2.13 Million	41,197 New	41,197 $1.63 Million
Q4 2021 Feb 14, 2022	SELL	$31.82 - $40.75 $2.6 Million - $3.33 Million	-81,637 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$38.47 - $46.42 $22 Million - $26.5 Million	-571,021 Reduced 87.49%	81,637 $3.32 Million
Q2 2021 Aug 13, 2021	BUY	$38.84 - $51.31 $3.73 Million - $4.92 Million	95,932 Added 17.23%	652,658 $29.6 Million
Q1 2021 May 17, 2021	BUY	$39.51 - $51.45 $17.5 Million - $22.8 Million	443,429 Added 391.39%	556,726 $23.2 Million
Q4 2020 Feb 16, 2021	SELL	$25.81 - $43.62 $762,737 - $1.29 Million	-29,552 Reduced 20.69%	113,297 $4.84 Million
Q3 2020 Nov 13, 2020	BUY	$25.74 - $29.63 $3.68 Million - $4.23 Million	142,849 New	142,849 $3.69 Million
Q2 2018 Aug 13, 2018	SELL	$16.87 - $20.3 $1.3 Million - $1.57 Million	-77,268 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$17.06 - $21.2 $348,689 - $433,306	-20,439 Reduced 20.92%	77,268 $1.51 Million
Q4 2017 Feb 09, 2018	BUY	$16.75 - $20.8 $1.64 Million - $2.03 Million	97,707	97,707 $1.98 Million

Others Institutions Holding HALO

# of Institutions

542

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Halozyme Therapeutics, Inc. Transaction History